Evidence map›Paper›PMID 29501900›Full record

ArticleAnnals of vascular surgery2018

Appropriate Use of Venous Imaging and Analysis of the D-Dimer/Clinical Probability Testing Paradigm in the Diagnosis and Location of Deep Venous Thrombosis.

Albeir Y Mousa, Mike Broce, David De Wit, Mina Baskharoun, Shadi Abu-Halimah, Michael Yacoub, Mark C Bates

Abstract readComparative Study
In one paragraph

Article in Annals of vascular surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Cost of Low-Value Imaging Worldwide: A Systematic Review.Applied health economics and health policy · 2024
    Pooled it
  2. D-dimer diagnostics: can I use any D-dimer assay? Bridging the knowledge-to-action gap.Research and practice in thrombosis and haemostasis · 2024
    Article
  3. Article
  4. The Diagnostic Efficacy of Age-Adjusted D-Dimer Cutoff Value and Pretest Probability Scores for Deep Venous Thrombosis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Albeir Y MousaDepartment of Surgery, Robert C. Byrd Health Sciences Center, West Virginia University & Charleston Area Medical Center, Charleston, WV. Electronic address: amousa@hsc.wvu.edu.
Mike BroceCenter for Health Services and Outcomes Research, Charleston Area Medical Center Health Education and Research Institute, Charleston, WV.
David De WitWest Virginia School of Osteopathic Medicine (WVSOM), Lewisburg, WV.
Mina BaskharounDepartment of Surgery, Robert C. Byrd Health Sciences Center, West Virginia University & Charleston Area Medical Center, Charleston, WV.
Shadi Abu-HalimahDepartment of Surgery, Robert C. Byrd Health Sciences Center, West Virginia University & Charleston Area Medical Center, Charleston, WV.
Michael YacoubDepartment of Surgery, Robert C. Byrd Health Sciences Center, West Virginia University & Charleston Area Medical Center, Charleston, WV.
Mark C BatesDepartment of Surgery, Robert C. Byrd Health Sciences Center, West Virginia University & Charleston Area Medical Center, Charleston, WV.

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Laura F. Gibson · 2012 to 2026
$81.0M
NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

backgroundThe D-dimer (DD) level combined with the pretest Wells criteria probability (WCP) score can safely exclude deep venous thrombosis (DVT). The objective of this study was to examine the correlation between DD results alongside WCP score with findings on venous duplex ultrasound (VDU). The hypothesis is that VDU remains overutilized in low-risk patients with negative DD and that higher DD levels may correlate with thrombus burden and location.

methodsPatients who presented to a high-volume tertiary care center with lower limb swelling with or without associated pain were retrospectively examined through June and July for 4 consecutive years (2012 to 2015). After calculating WCP, patients were divided into low-, moderate-, and high-risk categories. Electronic DD results utilizing enzyme linked immunosorbent assay, WCP data, and VDU analysis data were merged and analyzed based on receiver operator characteristic curve to determine the DD cutoff point for each WCP. Abnormal DD with an average value ≥ 0.6 mg/L fibrinogen equivalent units (FEUs) was correlated to positive DVT to differentiate proximal DVT (above popliteal vein) from distal DVT (below popliteal vein).

resultsData of 1,909 patients were analyzed, and 239 (12.5%) patients were excluded secondary to serial repeat visits or follow-ups, surveillance screens, and if they had a previous history of DVT. The average age was 62.1 ± 16.3 years with more women (55.7%) and the majority presented with limb pain and edema (87%). DD studies were ordered and completed in 202 patients and correlated with all positive and negative DVT patients (100% sensitivity and negative predictive value, with specificity and positive predictive value of 14.9% and 15.9%, respectively). Twenty-six of 202 patients had DD that were in the normal range 0.1-0.59 mg/L (FEU), all of which were negative for DVT (100% sensitive). Fifty one of 202 patients had DD values of 0.6-1.2 mg/L FEU, of which only 3 DVTs were recorded, and all of them were distal DVTs. In addition, 685 patients with WCP <1 and negative DD were sent for VDU. Thus, 762 patients had an unnecessary immediate VDU (Wells ≤1 and -DD) study during their initial presentation. Potential charge savings for VDU for all patients are 762 × $1,557 = $1,186,434 and DD for all patients are 762 × $182 = $138,684, with total potential savings of $1,047,750 (USD 2016).

conclusionsThis study suggests that DD is still underutilized, and DD in conjunction with WCP could significantly reduce the number of unnecessary immediate VDUs. Higher value of DD (>1.2 mg/L FEU) may raise concern for proximal DVT. Concern on cost-effectiveness exists and raises the demand for a proposed algorithm to be followed.

Indexed as

Ultrasonography, Doppler, DuplexAgedArea Under CurveBiomarkersClinical Decision-MakingCost-Benefit AnalysisCost SavingsDecision Support TechniquesFemaleFibrin Fibrinogen Degradation ProductsHealth Care CostsHospitals, High-VolumeHumansMaleMiddle AgedPredictive Value of TestsBiomarkersFibrin Fibrinogen Degradation Productsfibrin fragment D

Identifiers

PMID29501900
PMCPMC6014918

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.